Where Does Zentalis Pharmaceuticals Inc (ZNTL) Stock Fall in the Biotechnology Field After It Has Fallen -5.47% This Week?

A rating of 62 puts Zentalis Pharmaceuticals Inc (ZNTL) near the middle of the Biotechnology industry according to InvestorsObserver. Zentalis Pharmaceuticals Inc's score of 62 means it scores higher than 62% of stocks in the industry. Zentalis Pharmaceuticals Inc also received an overall rating of 48, putting it above 48% of all stocks. Biotechnology is ranked 73 out of the 148 industries.

ZNTL has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on ZNTL!

See Full ZNTL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 48 means the stock is more attractive than 48 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Zentalis Pharmaceuticals Inc Stock Today?

Zentalis Pharmaceuticals Inc (ZNTL) stock is lower by -0.62% while the S&P 500 is up 0.46% as of 12:06 PM on Wednesday, Oct 4. ZNTL is lower by -$0.12 from the previous closing price of $19.31 on volume of 144,529 shares. Over the past year the S&P 500 has gained 12.08% while ZNTL is lower by -13.56%. ZNTL lost -$4.82 per share the over the last 12 months. Click Here to get the full Stock Report for Zentalis Pharmaceuticals Inc stock.